About Pharmaelle
Pharmaelle is a company based in Bologna (Italy) founded in 2012 was acquired by Nutrisens in April 2023. Pharmaelle offers products and services including Barilife Supplements and Nutraceutica Products. Pharmaelle operates in a competitive market with competitors including Pfizer, AmerisourceBergen, CHEPLAPHARM, Entero Healthcare and EBOS Group, among others.
- Headquarter Bologna, Italy
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website pharmaelle.com
- Social LinkedIn Facebook
- Acquired by Nutrisens (Apr 2023)
- Legal Name Pharmaelle Srl
Products & Services of Pharmaelle
Pharmaelle offers a comprehensive portfolio of products and services, including Barilife Supplements and Nutraceutica Products.
Supplements designed for bariatric surgery recovery.
Products for gastrointestinal and neurological health needs.
Investors in Pharmaelle
Pharmaelle has secured backing from 1 investor. Prominent investors backing the company include Nutrisens.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Personalized nutrition and diet plans are provided online. | 2006 | nutrisens.com | Francheville, France |
Investor details for Pharmaelle
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Pharmaelle
1 people are tracked at Pharmaelle (1 in leadership).
| Name | Role | Group |
|---|---|---|
Roberto Vico | CEO | Leadership |
Complete people profiles for Pharmaelle
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Pharmaelle
2 dated milestones of Pharmaelle across 11 years, from founding to its latest funding, stage changes and deals.
- Founded Pharmaelle is founded.
- Exit Acquired by Nutrisens.
Competitors of Pharmaelle
Pharmaelle operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pfizer, AmerisourceBergen, CHEPLAPHARM, Entero Healthcare and EBOS Group, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| pfizer.com | 1849 | New York, United States | $8M | – | Pharmaceutical products for treating multiple diseases are provided. | |
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| cheplapharm.com | 1998 | Mesekenhagen, Germany | – | 840 | Branded pharmaceutical products are developed, marketed, and distributed globally. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| ebosgroup.com | 1922 | Docklands, Australia | – | – | Wholesaler & distributor of healthcare, medical, and pharmaceutical products | |
| renee.com | 2021 | Los Angeles, United States | $8.2M | – | Diversified drugs are distributed by Renee in the United States. | |
| dizalpharma.com | 2017 | Pudong, China | $100M | – | Pharmaceutical research and development are focused on oncology therapeutics. | |
| target-healthcare.co.uk | 2012 | East Kilbride, United Kingdom | $26.15M | 45 | Distributor of pharmaceutical products | |
| neuca.pl | 1990 | Torun, Poland | – | – | Wholesale distribution of pharmaceuticals is managed by NEUCA in Poland. | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. |
Detailed competitors of Pharmaelle
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Pharmaelle
The website of Pharmaelle (pharmaelle.com) receives about 5.6K visits a month.
- Monthly visits5.6K
▲ 37% vs previous month
Latest news on Pharmaelle
Complete news archive for Pharmaelle
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Pharmaelle
10 companies that operate in the same segment as Pharmaelle (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Pharmaelle
Pharmaelle was founded in 2012.
Pharmaelle is headquartered in Bologna, Italy. It is registered at Bologna, Emilia-romagna, Italy.
Roberto Vico is the current CEO of Pharmaelle.
Pharmaelle was established in 2012 in Bologna, Italy, as a distributor within the pharmaceutical sector. Operations focus on the supply and distribution of pharmaceutical products to various markets. The company is led by CEO Roberto Vico. Activities are centered in Italy, with emphasis on efficient logistics and regulatory compliance in the healthcare supply chain. No additional international expansions are noted.
Pharmaelle's top competitors include Pfizer, Entero Healthcare and AmerisourceBergen.
Pharmaelle offers Barilife Supplements and Nutraceutica Products.
Pharmaelle has 1 investor. Key investors include Nutrisens.
Pharmaelle operates through Pharmaelle Srl.
Yes. Pharmaelle was acquired by Nutrisens in April 2023.